Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly | Lima | Salute | Prodotti farmaceutici | 2,64 Bln PEN | 85,4x | 1,32 | 3.146,62 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
UnitedHealth | Lima | Salute | Fornitori e servizi sanitari | 1,77 Bln PEN | 33,8x | -1,06 | 2.085,19 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Johnson & Johnson | Lima | Salute | Prodotti farmaceutici | 1,31 Bln PEN | 24x | -0,45 | 556,96 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
AbbVie | Lima | Salute | Prodotti farmaceutici | 1,14 Bln PEN | 60,5x | -2,86 | 705,65 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Lima | Salute | Prodotti farmaceutici | 960,33 Mrd PEN | 21,4x | 0,13 | 382,98 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thermo Fisher Scientific | Lima | Salute | Attrezzature e forniture medicali | 749 Mrd PEN | 32,9x | 7,24 | 2.263,24 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pfizer | Lima | Salute | Prodotti farmaceutici | 542,45 Mrd PEN | 34,1x | -0,57 | 95,69 PEN | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Gilead Sciences | Lima | Salute | Prodotti farmaceutici | 425,85 Mrd PEN | 910,7x | -9,31 | 358,84 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bristol Myers Squibb | Lima | Salute | Prodotti farmaceutici | 420,02 Mrd PEN | -15,5x | 0,09 | 225,17 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regeneron Pharmaceuticals | Lima | Salute | Ricerca medica e biotecnologica | 292,77 Mrd PEN | 16,9x | 1,17 | 3.959,28 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CVS Health | Lima | Salute | Fornitori e servizi sanitari | 232,04 Mrd PEN | 12,5x | -0,34 | 189,13 PEN | -4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Moderna | Lima | Salute | Ricerca medica e biotecnologica | 59,80 Mrd PEN | -7,2x | -0,22 | 156,29 PEN | -3,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |